Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07519135 · ClinicalTrials.gov registry record · Phase 1
A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function
A Phase 1 study, sponsored by Pfizer.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT07519135 is a Phase 1 study that is actively recruiting participants, run by Pfizer. The registered enrollment target is 26 participants.
The verdict
NCT07519135, a Phase 1 study, is actively recruiting participants, sponsored by Pfizer.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study is being done to learn more about an investigational medicine called PF-08653944. The goal is to understand how the body handles the medicine and to check its safety after a single dose. The study includes adults with normal liver function and adults who have mild, moderate, or severe liver problems. By comparing these groups, researchers want to understand whether liver function changes how the medicine behaves in the body. People who join the study will receive one injection of the study medicine. They will stay at the study clinic for a short time and return for follow-up visits so doctors can do blood tests, physical exams, and safety checks. This study is not expected to provide direct medical benefit to participants. The information collected will help researchers develop future treatments and understand how this medicine may be used safely in people with liver disease.
Interventions
- DRUG PF-08653944
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2026-04-15 |
| Est. Completion | 2027-07-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07519135
The ClinicalTrials.gov registry entry for NCT07519135 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PF-08653944 is the first listed.
NCT07519135 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07519135 about?
NCT07519135 is a clinical study titled "A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function". This study is being done to learn more about an investigational medicine called PF-08653944. The goal is to understand how the body handles the medicine and to check its safety after a single dose. The study includes adults with normal liver function and adults who have mild, moderate, or severe li...
What is the current status of trial NCT07519135?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2026-04-15. Estimated completion is 2027-07-09.
What interventions are being tested in trial NCT07519135?
The interventions under investigation include: PF-08653944 (DRUG).
Who is sponsoring clinical trial NCT07519135?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.